Apollo's $10B Jet Set & Biogen's $5.6B Rare Disease Play

Apollo Global Management is reportedly closing in on a massive $10 billion acquisition of US private jet services provider Atlantic Aviation. The blockbuster deal would see Apollo taking the reins from fellow private equity heavyweight KKR & Co. This transaction highlights the continued, aggressive private equity appetite for high-end aviation infrastructure and services. Also: Biogen has agreed to acquire Apellis Pharmaceuticals for $5.6 billion, or $41 per share plus a contingent value right, to bolster its immunology and rare disease portfolio.; Carlyle is acquiring a majority stake in MAI Capital Management in a transaction that values the wealth management firm at over $2.8 billion.; Tokyo-based Otsuka Pharmaceutical is snapping up clinical-stage biotech Transcend Therapeutics for $700 million upfront and up to $525 million in future milestones.

---

Subscribe for daily M&A insights and deal analysis.

Sign up free: https://ololand.ai/signup?ref=youtube

Free tools:
CIM Analyzer: https://ololand.ai/tools/cim-analyzer
Valuation Calculator: https://ololand.ai/tools/valuation-calculator
Academic Paper Publisher: https://ololand.ai/tools/academic-paper-publisher

#MergersAndAcquisitions #PrivateEquity #DueDiligence #DealStreetDaily #AI #SearchFunds

Видео Apollo's $10B Jet Set & Biogen's $5.6B Rare Disease Play канала ololandai